Call for Papers
(Specific to Therapeutic Disease)
Applications of Modern Molecular Biology to Vaccine Development
Authors Guide:
The Mayo Clinic's Richard Kennedy, Manish Sadarangani (BC Children's Hospital Research Institute), Tobias Kollmann (Telethon Kids Institute), and the Journal of Molecular Biology are organizing a special issue on "Applications of Modern Molecular Biology to Vaccine Development."
Submission:
The journal publishes original scientific research papers that describe significant advancements in the field and provide mechanistic and functional insights.
Therapeutic disease:
This special issue will cover all phases of molecular biology, including how modern tools, methodologies, and model systems are being used to understand host-pathogen interactions better, characterize the host response to infection and vaccination more comprehensively, and develop safe and effective vaccines more quickly. The history of various vaccine types, unique techniques for developing new vaccines and improving current ones, and major emergent concepts altering how we produce, test, and deploy vaccines will be covered in reviews and research papers.
Pubrica Offers:
We provide comprehensive treatment knowledge in a wide range of indications. Pubrica Scientific Writing & Publication customize clinical trial services to meet your individual needs; we offer full program creation and delivery services for any trial phase you wish to outsource or salvage a failing study. Allow our specialists to express themselves through new ideas and unique techniques. Our staff includes clinical research associates, project managers, medical supervisors, data management experts, biostatisticians, and medical writers who are available at all stages of the trial, including trial planning, design, protocol development, safety narratives, in-house data summaries, safety surveillance plan, Case Report Form (CRF), site selection, data analysis, and regulatory submissions. As a result, create cost-effective clinical research studies that provide the data you need to support your innovative therapeutics.
